Global Orthopaedic Technology (GOT), which bills itself as the largest Australian-owned orthopaedic implant designer and manufacturer, was established in 1999 and serves Australia and the U.S.—two markets in which Corin has an established presence.... Read more »
Medtronic, DePuy Synthes, Stryker and Globus Medical—four of the five largest spine companies ranked by revenue—announced acquisitions in the last month. We recap the additions to their product portfolios.... Read more »
K2M’s innovative technology platform will add a suite of complex spine solutions to Stryker’s core spine portfolio; K2M’s consistent support of additive manufacturing of devices could also benefit Stryker’s long-term growth.... Read more »
Cartiva’s Synthetic Cartilage Implant is used to treat arthritis in the great toe. Wright’s $435MM purchase of the technology (expected to close in 4Q18) enhances its position in the space by providing access to what company leadership described as a ~$420MM addressable market.... Read more »
This acquisition expands the U.S.-based analytical testing capabilities of Nelson Laboratories.... Read more »
Financial terms of the purchase were not disclosed; Medbio specializes in precision injection molding, instrument manufacturing, laser processing, packaging and component parts.... Read more »
As the number one-ranked contract manufacturer serving the orthopaedic market, based on 2017 ORTHOWORLD revenue estimates, the purchase aligns with Tecomet's recent M&A activity. HD Surgical manufactures high-precision instruments and possesses a wide array of machining capabilities.... Read more »
The transaction, announced in May, was valued at U.S. $600MM.... Read more »
This acquisition is part of Röchling’s strategy to grow its U.S. business.... Read more »
The purchase of Nanosurfaces Industries is expected to boost Eurocoating’s additive capabilities.... Read more »
The transaction, of which financial terms were not disclosed, directly aligns with In'Tech’s recent strategic focus on global expansion. ... Read more »
The sale, which closes in 3Q18 and is for $600MM in cash, adds a range of metals manufacturing capabilities (e.g. machining, stamping, coating and metal forming) for MedPlast, as well as design, development and prototyping services. ... Read more »
The contract manufacturer will join the MW Medical Solutions brand.... Read more »
Cadence’s leadership and management team will remain in place post-transaction.... Read more »
The recent acquisition of Paragon Medical, coupled with purchases of several other household names during the past three years, means that NN has positioned itself as a top-five contract manufacturing player. ... Read more »
The acquisition, at a price of $375MM in cash, will close during 2Q18 and positions NN as one of the 10 largest contract manufacturers in orthopaedics.... Read more »
Oberg’s manufacturing capabilities increase with the acquisition.... Read more »
Over an eight-year span, the gap between the number of OEM transactions versus those in the supplier space was its narrowest in 2017.... Read more »
Zyga Technology is the developer of the SImmetry® Sacroiliac Joint Fusion system.... Read more »
With the recent M&A activity in the supplier space, all OEMs should be prepared in the event an important supplier is acquired or merged with.... Read more »
MinebeaMitsumi acquired C&A Tool Engineering to expand its presence in medical, additive manufacturing, precision machining and ball bearings.... Read more »
In fewer than 18 years, Mike Miller founded and led Stealth Technologies from a five-man operation supplying high-performance auto parts to its existence today as Orchid Orthopedic Solutions, one of the larger contract manufacturers in orthopaedics.... Read more »
Proper implementation post-close will allow your supply chain to deliver immediate and long-term value and avoid integration delays and disruptions.... Read more »
OrthoPlastics is a global supplier of UHMWPE to orthopaedic device manufacturers.... Read more »
The primary responsibility of the supply chain team post-M&A is the assurance of uninterrupted upstream and downstream product supply. These essential steps will assist you in identifying supply chain risk and developing a plan to minimize that risk.... Read more »
The transaction supports Tecomet's strategic priority to lead in the minimally invasive market.... Read more »
Avoid disruptions in customer service and financial performance by reviewing the people, processes and supporting systems of upstream and downstream supply chains.... Read more »
Instratek markets staple and hammertoe implants and instrumentation for foot, ankle and upper extremity procedures. The transaction is expected to close in 4Q16.... Read more »
In efforts to invigorate revenue growth, Medtronic and Zimmer Biomet have focused on niche technologies that expand their portfolios—but have yet to prove wide scale adoption.... Read more »
Tecomet, manufacturer of precision engineered components supporting the medical device industry, has appointed Mark Kemp to the position of President and Chief Executive Officer.
Kemp brings a wealth of medical device experience to this new role. Previously, he spent 16 years with Flextronics in pr... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Consolidation has picked up at the supplier level as manufacturers seek to meet the needs of OEM customers that are also expanding through consolidation.... Read more »
Given healthy balance sheets and cheap debt, large and mid-sized buyers are well positioned to pursue acquisition opportunities in 2018 and beyond. CEOs seeking to buy or sell should consider these best practices and expert tips.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
